Facebook
Twitter
LinkedIn
Forward
Case-Based Discussions on the Corneal Nerve in Ocular Surface Disease (Archived CE Webcast)
This educational activity has expired. You will not be able to claim credit for this activity.
Activity Description and Purpose
Corneal nerves have an essential role in maintaining ocular surface health and homeostasis. Manifestations of neurosensory abnormalities affecting corneal innervation include dry eye disease and neurotrophic keratopathy. These conditions can exist as a standalone entity, but they can also be concurrent and have overlapping features, making diagnosis challenging. Early diagnosis is important to allow intervention that can help to restore function and improve quality of life. This educational activity includes real-world cases and discussion on diagnostic modalities used to identify these conditions and options for treatment. The desired results of this educational activity are to familiarize optometrists with the role of the corneal nerve in maintaining ocular surface homeostasis and practical strategies for screening and diagnosing of ocular surface disease that can arise as the result of corneal nerve dysfunction.
Target Audience
This educational activity is intended for optometrists.
Learning Objectives
After completing this activity, participants will be better able to:
- Review diagnostic modalities used for proper assessment of ocular surface disease
- Integrate evaluation of corneal sensitivity into assessment of ocular surface disease
Faculty
 | Douglas K. Devries, OD (Co-Chair) |
 | Kendall E. Donaldson, MD, MS (Co-Chair)
|
 | Jaclyn Garlich, OD |
 | Christopher E. Starr, MD, FACS |
Disclosure Policy
The content of this COPE-accredited CE activity was planned and prepared independently by MedEdicus without input from members of an ineligible company. All relevant relationships with ineligible companies have been mitigated.
Faculty
Douglas K. Devries, OD, is a consultant for Alcon, Allergan, Avellino, Azura Ophthalmics Ltd, Bausch & Lomb Incorporated, Bruder Healthcare, Dompé US, Inc, Eyevance, Johnson & Johnson Vision Care, Inc, Kala Pharmaceuticals, Lumenis, Novartis Pharmaceuticals Corporation, OCuSOFT Inc, Oyster Point Pharma, Inc, ScienceBased Health, Sight Sciences, Sun Pharmaceutical Industries, Inc, Tarsus Pharmaceuticals, Inc, TearLab Corporation, Thea Pharmaceuticals Limited, and Visus Therapeutics; and is on the speakers bureau of Alcon, Bausch & Lomb Incorporated, Dompé US, Inc, Eyevance, Kala Pharmaceuticals, Johnson & Johnson Vision Care, Inc, Lumenis, Novartis Pharmaceuticals Corporation, OCuSOFT Inc, Oyster Point Pharma, Inc, ScienceBased Health, Sight Sciences, and Sun Pharmaceutical Industries, Inc.
Kendall E. Donaldson, MD, MS, is a consultant for AcuFocus, Inc, Alcon, Allergan, Bausch & Lomb Incorporated, Dompé US, Inc, Eyevance, Johnson & Johnson Vision Care, Inc, Kala Pharmaceuticals, Lumenis, Omeros Corporation, ScienceBased Health, Tarsus Pharmaceuticals, Inc, and Zeiss.
Jaclyn Garlich, OD, is a consultant for Lumenis; and is an advisory board member of Allergan, Bruder Healthcare, Dompé US, Inc, Novartis Pharmaceuticals Corporation, Orasis Pharmaceuticals, Tarsus Pharmaceuticals, Inc, and Thea Pharmaceuticals Limited.
Christopher E. Starr, MD, is a consultant for Aerie Pharmaceuticals, Inc, Aldeyra Therapeutics, Allergan, Bruder Healthcare, Dompé US, Inc, EyeBio, Johnson & Johnson Vision Care, Inc, Kala Pharmaceuticals, Novartis Pharmaceuticals Corporation, Oyster Point Pharma, Inc, Quidel Corporation, Sun Pharmaceutical Industries, Inc, Tarsus Pharmaceuticals, Inc, TearLab Corporation, and Verséa Health, Inc; and has individual stocks and stock options in Èssiri Labs.
Peer Reviewer
This activity was peer reviewed. The peer reviewer has no relevant commercial relationships to disclose.
Planners, Managers, and Writers
MedEdicus planners, managers, and writers have no relevant commercial relationships to disclose.
Accreditation Statement
COPE approved for 1.0 CE credit for optometrists.
COPE Course ID: 86936-TD (Asynchronous)
COPE Course Category: Treatment/Management of Ocular Disease
Administrator: 
This activity, COPE Activity Number 126783, is accredited by COPE for continuing education for optometrists.
Disclosure of Commercial Support
MedEdicus LLC has received commercial support from Dompé US, Inc, for this activity in the form of an unrestricted educational grant.
The content of this COPE-Accredited CE activity was planned and prepared independently by MedEdicus LLC without input from members of an ineligible company.
Off-Label Discussion
This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.
Sponsored by 
Provider Contact Information
For questions about this educational activity, please contact MedEdicus LLC at info@mededicus.com.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of State University of New York College of Optometry, MedEdicus LLC, or Dompé US, Inc.
This CE activity is copyrighted to MedEdicus LLC ©2023. All rights reserved. 266.3